Course Description: This seminar will review the role of pharmacokinetic image analysis of DCE-MRI for lesion detection, localization, stage, treatment planning, and serial monitoring of cancers in the prostate, liver, brain, and other organs. Speakers will discuss how they use quantitative parameters including Ktrans (PERM), Kep, and VE to analyze tissue, plan interventional procedures and treatment options, and how this date impacts clinical outcomes.
